• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 789-803 of 973 results

1113 Exhibit: Exhibit 1113 Skrivanek

Document IPR2023-00724, No. 1113 Exhibit - Exhibit 1113 Skrivanek (P.T.A.B. May. 22, 2024)

cite Cite Document

2546 Exhibit: EX2546 Petitioner’s Motion for Joinder Under 35 USC 315c and 37 C...

Document IPR2023-00724, No. 2546 Exhibit - EX2546 Petitioner’s Motion for Joinder Under 35 USC 315c and 37 CFR 4222 and 42122b, Sun Pharmaceutical Industries Ltd v Novo Nordisk AS, IPR2024 0...

cite Cite Document

... John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 122...

Document IPR2023-00724, No. 2537 Exhibit - EX2537 Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 122 cv 03038 CFC D D

cite Cite Document

1140 Exhibit: Exhibit 1140 Goland Dep

Document IPR2023-00724, No. 1140 Exhibit - Exhibit 1140 Goland Dep (P.T.A.B. May. 22, 2024)

cite Cite Document

2058 Exhibit: EX2058 Declaration of Sayem Osman

Document IPR2023-00724, No. 2058 Exhibit - EX2058 Declaration of Sayem Osman (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2056 Exhibit: EX2056 EX2056 Declaration of Patrick Sinko, PhD REDACTED

Document IPR2023-00724, No. 2056-2 Exhibit - EX2056 EX2056 Declaration of Patrick Sinko, PhD REDACTED (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2081 Exhibit: EX2081 Dani Blum, What’s Next for Ozempic, New York Times, Decem...

Document IPR2023-00724, No. 2081 Exhibit - EX2081 Dani Blum, What’s Next for Ozempic, New York Times, December 20, 2023 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

1025 Exhibit: Glaesner 2010

Document IPR2023-00724, No. 1025 Exhibit - Glaesner 2010 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

2555 Exhibit: EX2555 REDACTED Transcript of July 19, 2024 Deposition of DeFore...

Document IPR2023-00724, No. 2555-2 Exhibit - EX2555 REDACTED Transcript of July 19, 2024 Deposition of DeForest McDuff (P.T.A.B. Aug. 5, 2024)

cite Cite Document

2536 Exhibit: EX2536 Partial Transcript of July 22, 2024 Conference Call

Document IPR2023-00724, No. 2536 Exhibit - EX2536 Partial Transcript of July 22, 2024 Conference Call (P.T.A.B. Jul. 25, 2024)

cite Cite Document

1311 Exhibit: Exhibit 1311 Redacted Flint Dep

Document IPR2023-00724, No. 1311 Exhibit - Exhibit 1311 Redacted Flint Dep (P.T.A.B. Jun. 21, 2024)

cite Cite Document

2550 Exhibit: EX2550 Sun Pharmaceutical Industries Ltd’s and Sun Pharmaceutic...

Document IPR2023-00724, No. 2550 Exhibit - EX2550 Sun Pharmaceutical Industries Ltd’s and Sun Pharmaceutical In dustries Inc’s Stipulation of Invalidity Contentions, In re Ozempic Semaglutide Pate...

cite Cite Document

2075 Exhibit: EX2075 Madsbad, S et al, “Improved Glycemic Control With No Weigh...

Document IPR2023-00724, No. 2075 Exhibit - EX2075 Madsbad, S et al, “Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once Daily Treatment With the Long Ac...

cite Cite Document

2452 Exhibit: EX2452 Synjardy Prescribing Information rev Dec 2017

Document IPR2023-00724, No. 2452 Exhibit - EX2452 Synjardy Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2385 Exhibit: EX2385 Wilding, JPH, The importance of weight management in type ...

Document IPR2023-00724, No. 2385 Exhibit - EX2385 Wilding, JPH, The importance of weight management in type 2 diabetes mellitus, Int J Clin Pract, 2014 Jun 686682 691 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
<< 1 2 3 4 5 ... 53 54 55 56 57 ... >>